Wireless brain implant can be controlled over the internet in rodents

The device is called RAPIDO, short for a remotely actuated and programmable implant for drug delivery and optical stimulation. It brings several functions into one miniaturized implant: a system for delivering a drug, a tiny light source and wireless controls.

Optical stimulation, also called optogenetics, uses light to influence specially prepared nerve cells. It is a research method used to study how particular brain circuits relate to behavior. The study describes this work in freely moving rodents, rather than in people.

According to the study abstract, the implant has a replaceable, refillable drug cartridge with a one-way valve. The authors say this design is meant to avoid contamination flowing back into the device. An electrochemical pump can be programmed for different flow rates and for doses that change in a linear way.

The system has two wireless control options. Researchers can use a smartphone for nearby, interactive experiments. They can also use internet connectivity to schedule operation remotely, without a researcher being present beside the animal.

That remote feature was highlighted in the accompanying news coverage. It reported that a researcher in Chicago operated an implant in Daejeon, South Korea, through the internet. The primary study abstract supports internet-connected, remotely scheduled operation, but does not give details on how often the intercontinental demonstration was tested or on connection failures.

In rodents, the researchers reported that the implant supported repeated wireless drug-based changes in locomotor behavior, meaning movement. It also supported independent optogenetic manipulation of intracellular signaling during cocaine conditioning. Cocaine conditioning is an animal research setup used to examine learned responses associated with cocaine exposure.

The news coverage describes an experiment combining cocaine delivery with light stimulation and says addiction-related behavioral responses were suppressed. The study abstract uses more limited language: it reports drug-based movement changes and separate light-based manipulation during cocaine conditioning. The supplied material does not provide the size or duration of any behavioral effect, how behavior was measured, or the comparison groups.

The work is therefore best understood as a preclinical technology demonstration. It may help researchers run longer studies of brain circuits while reducing the need to handle animals repeatedly or remain nearby during an experiment. The device's replaceable cartridge could also make repeated dosing studies more practical.

But the findings do not show that the implant can treat addiction, brain disorders or any other condition in people. The supplied information does not report human testing, human safety data, side effects, or how a device like this would work outside a controlled research setting. Further animal research and, if appropriate, carefully designed human studies would be needed before its medical potential could be judged.